1-3 of 3
Authors: Matthew R Grimmer
Journal Article
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas Free
Neuro-Oncology, Volume 23, Issue 11, November 2021, Pages 1872–1884, https://doi.org/10.1093/neuonc/noab081
Published: 05 April 2021
Journal Article
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence Free
Neuro-Oncology, Volume 22, Issue 11, November 2020, Pages 1580–1590, https://doi.org/10.1093/neuonc/noaa059
Published: 13 March 2020
Journal Article
Temozolomide-associated hypermutation in gliomas Free
Neuro-Oncology, Volume 20, Issue 10, October 2018, Pages 1300–1309, https://doi.org/10.1093/neuonc/noy016
Published: 14 February 2018
